Concurrent, Prolonged Use of Bedaquiline and Delamanid for Multidrug-Resistant Tuberculosis
Dong-Gon HYUN; Se-Hee LEE; Kyung-Wook JO; Tae-Sun SHIM.
Korean Journal of Medicine
; : 294-298, 2019.
Artículo en Inglés | WPRIM | ID: wpr-938620
Documentos relacionados
Concurrent, Prolonged Use of Bedaquiline and Delamanid for Multidrug-Resistant Tuberculosis
Peritonitis tuberculosa: revisión de 16 años en un hospital general
Biomedical research in france and brazil: an analysis of significant differences and ethical issues
Bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis: a multicentre cohort study in Korea.
Seguridad de abatacept en pacientes con artritis reumatoidea
Compassionate use of delamanid in adults and children for drug-resistant tuberculosis: 5-year update.
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis.
Emergence of Low-level Delamanid and Bedaquiline Resistance During Extremely Drug-resistant Tuberculosis Treatment.